5 мар. 2024 г. · The American College of Chest Physicians (CHEST) Antithrombotic Therapy for Venous Thromboembolism Disease evidence-based guidelines are now ...

3 авг. 2021 г. · CHEST Press Releases CHEST releases new guidelines for antithrombotic therapy for VTE disease ... © 2024 | American College of Chest Physicians®.

August 2024, Pages 388-404. Journal home page for ... anticoagulation over anticoagulation (Weak Recommendation, Low-Certainty Evidence). ... The CHEST Guidelines ...

7 окт. 2024 г. · ESC/ERS, ASH, and CHEST recommend ≥3 months of therapeutic anticoagulation for primary treatment of acute PE. ESC/ERS recommend extended ...

Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021. Chest. 2024 Aug;166(2):388-404. doi: 10.1016/j.chest.2024.03.003.

23 нояб. 2022 г. · In patients who require perioperative heparin bridging of anticoagulation therapy: Stop intravenous unfractionated heparin (UFH) ≥4 hours prior ...

The ninth edition of the CHEST guideline recommends serial ultrasound in 1–2 weeks without anticoagulation if the thrombus does not extend proximally. However, ...

The latest update to the American College of Chest Physicians guideline regarding antithrombotic therapy for VTE adds four new recommendations and updates eight ...

21 янв. 2022 г. · CHEST recently updated its 2016 guideline on antithrombotic therapy for VTE based on newer evidence that has further informed the standard ...

1 апр. 2024 г. · The 2021 CHEST guidelines recommend anticoagulation for at least 3 months for patients with a high risk of thrombus extension (Table 1) as these ...